ABOS
Price
$2.42
Change
+$0.01 (+0.42%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
172.26M
55 days until earnings call
Intraday BUY SELL Signals
LXRX
Price
$2.16
Change
+$0.01 (+0.47%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
955.02M
37 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ABOS vs LXRX

ABOS vs LXRX Comparison Chart in %
View a ticker or compare two or three
VS
ABOS vs. LXRX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a Hold and LXRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2026
Stock price -- (ABOS: $2.38 vs. LXRX: $2.15)
Brand notoriety: ABOS and LXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABOS: 166% vs. LXRX: 119%
Market capitalization -- ABOS: $172.26M vs. LXRX: $955.02M
ABOS [@Biotechnology] is valued at $172.26M. LXRX’s [@Biotechnology] market capitalization is $955.02M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green whileLXRX’s FA Score has 1 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • LXRX’s FA Score: 1 green, 4 red.
According to our system of comparison, LXRX is a better buy in the long-term than ABOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 5 TA indicator(s) are bullish while LXRX’s TA Score has 5 bullish TA indicator(s).

  • ABOS’s TA Score: 5 bullish, 3 bearish.
  • LXRX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both ABOS and LXRX are a good buy in the short-term.

Price Growth

ABOS (@Biotechnology) experienced а +1.92% price change this week, while LXRX (@Biotechnology) price change was +9.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.89%. For the same industry, the average monthly price growth was +2.09%, and the average quarterly price growth was +1952.22%.

Reported Earning Dates

ABOS is expected to report earnings on Aug 17, 2026.

LXRX is expected to report earnings on Jul 30, 2026.

Industries' Descriptions

@Biotechnology (+5.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LXRX($955M) has a higher market cap than ABOS($172M). LXRX YTD gains are higher at: 86.957 vs. ABOS (13.033). LXRX has higher annual earnings (EBITDA): -17.44M vs. ABOS (-108.82M). LXRX has more cash in the bank: 171M vs. ABOS (128M). ABOS has less debt than LXRX: ABOS (31.2M) vs LXRX (57.7M). LXRX has higher revenues than ABOS: LXRX (69.6M) vs ABOS (0).
ABOSLXRXABOS / LXRX
Capitalization172M955M18%
EBITDA-108.82M-17.44M624%
Gain YTD13.03386.95715%
P/E RatioN/AN/A-
Revenue069.6M-
Total Cash128M171M75%
Total Debt31.2M57.7M54%
FUNDAMENTALS RATINGS
LXRX: Fundamental Ratings
LXRX
OUTLOOK RATING
1..100
20
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
27
SEASONALITY SCORE
1..100
27

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABOSLXRX
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 9 days ago
87%
Declines
ODDS (%)
Bearish Trend 8 days ago
87%
Bearish Trend 21 days ago
85%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ABOS
Daily Signal:
Gain/Loss:
LXRX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MECDX16.710.01
+0.06%
NYLI Epoch Capital Growth Class A
GISOX21.23N/A
N/A
Grandeur Peak Intl Stalwarts Inv
JLGPX84.71N/A
N/A
JPMorgan Large Cap Growth R3
FLKSX17.26N/A
N/A
Fidelity Low-Priced Stock K6
MAGKX18.06N/A
N/A
MoA Small Cap Growth Fund